Treatment patterns and real-world clinical outcomes in patients with advanced endometrial cancer that are non-microsatellite instability high (non-MSI-high) or mismatch repair proficient (pMMR) in the United States

• Prif Awduron: Sneha S. Kelkar (Awdur), Vimalanand S. Prabhu (Awdur), Jingchuan Zhang (Awdur), Shelby Corman (Awdur), Cynthia Macahilig (Awdur), Nifasha Rusibamayila (Awdur), Shardul Odak (Awdur), Linda R. Duska (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Elsevier, 2022-08-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Objective: Microsatellite instability (MSI) due to defective DNA mismatch repair has emerged as an actionable biomarker in advanced endometrial cancer (aEC). Currently, there are no treatment patterns and outcomes data in non-MSI-high (non-MSI-H) or mismatch repair proficient (pMMR) aEC patients fol...